Making A Title Slide - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Making A Title Slide

Description:

It is conducted in a non-punitive environment with the ultimate goal to create a ... Identify contributing factors of failure modes. Redesign process ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 16
Provided by: NMH69
Category:

less

Transcript and Presenter's Notes

Title: Making A Title Slide


1
The Application of FMEA to a Medication
Reconciliation Process
Presented to Date By Insert Name
2
Presentation Overview
  • Introduction to Failure Mode and Effects Analysis
    (FMEA) and Its Utilization In Healthcare
  • Application of FMEA to a Medication
    Reconciliation Process Upon Admission to the
    Hopsital
  • Pilot Data Collection
  • Lessons Learned / Closing Comments
  • Questions and Discussion

3
Introduction to Failure Mode and Effects Analysis
(FMEA) and Its Utilization In Healthcare
4
What is FMEA?
  • This method, used by other high-risk industries,
    is defined as follows
  • An FMEA can be described as a systematic group
    of activities intended to (a) recognize and
    evaluate the potential failure of a
    product/process and the effects of that failure,
    (b) identify actions that could eliminate or
    reduce the chance of the potential failure
    occurring, and (c) document the entire process.
    It is complementary to the process of defining
    what a design or process must do to satisfy the
    customer. All FMEAs focus on the design, whether
    it be of the product or process.

From Potential Failure Mode and Effects Analysis
(FMEA) 3rd Edition. Reference manual developed
by the FMEA teams at Chrysler, Ford and General
Motors working under the auspices of the
Automotive Division of the American Society for
Quality Control (ASQC) and the Automotive
Industry Action Group (AIAG)
5
Why Utilize FMEA in Healthcare?
  • The Joint Commission on Accreditation of
    Healthcare Organizations (JCAHO) Standard LD 5.2
    requires healthcare organizations to perform
    annually at least one proactive assessment of a
    high-risk process.
  • FMEA has been proven to be effective in other
    high risk industries such as nuclear power,
    aviation and automotive.
  • Historically, healthcare has assessed issues,
    once an incident occurred, using a Root Cause
    Analysis (RCA). FMEA is a prospective approach.

6
RCA versus FMEA
  • Retrospective
  • Reactive. RCA is utilized after a near-miss or
    sentinel event and is impacted by hindsight bias.
  • RCA team may not engage those directly involved
    in the incident. The environment may appear as
    punitive and may be emotional due to the
    situation at hand.
  • Prospective
  • Proactive. FMEA is utilized to prevent a
    near-miss or sentinel event from occurring by
    identifying potential problems that exist and
    correcting the process.
  • FMEA team is multi-disciplinary and includes
    front-line personnel. It is conducted in a
    non-punitive environment with the ultimate goal
    to create a safer system or process.

7
HealthCare Process FMEA Steps
  • Select a high-risk process and assemble a team.
  • Diagram the process.
  • Brainstorm potential failure modes
  • Estimate the severity of the failure
  • Estimate the probability of occurrence
  • Estimate the probability of detection
  • Calculate the risk priority number
  • Prioritize failure modes
  • Identify contributing factors of failure modes
  • Redesign process
  • Analyze and test the new process
  • Implement and monitor the redesigned process

8
Calculating a Risk Priority Number
  • Each severity (S), occurrence (O) and detection
    (D) can be ranked using a scale from 1 to 10,
    with 1 corresponding to low risk and 10
    corresponding to high risk.
  • The Risk Priority Number (RPN) can be determined
    by the following equation
  • Severity Rank (S) x Occurrence Rank (O) x
    Detection Rank (D) RPN
  • The RPN directs the team to areas of greatest
    potential for harm. Recommendations for
    corrective actions can be developed and
    prioritized based on results.

9
Application of FMEA to a Medication
Reconciliation Process Upon Hospital Admission
10
Failure Modes Identified
  • Inaccurate , incomplete and/or missing
    information on patients admission medication
    histories
  • No formalized approach for obtaining and
    documenting medication histories within patients
    medical records
  • Inconsistencies between histories obtained by
    various disciplines and documented throughout
    patients medical records

11
Examples of Rating Failure Modes
  • Failure Mode Independent medication histories
    throughout medical record with conflicting
    information about patients medication history
  • 10 (S) x 10 (O) x 7 (D) 700 RPN
  • Failure Mode Inaccurate medication history
    obtained
  • 10 (S) x 8 (O) x 7 (D) 560 RPN
  • Failure Mode Incomplete and/or incorrect
    medication orders upon admission
  • 10 (S) x 9 (O) x 8 (D) 720 RPN

12
Medication Reconciliation Upon Admission
  • Recommendations made by FMEA team
  • Create single, shared medication list accessible
    to all authorized health care providers
  • Obtain an accurate and complete medication list
    upon admission
  • Consider use of pharmacy resources for obtaining
    medication histories in appropriate cases
    (pharmacy consult)
  • Develop a formalized process for medication
    reconciliation
  • Incorporate medication reconciliation into an
    advanced clinical information system

13
Lessons Learned / Closing Comments
  • Hospital leadership, the teams time and
    commitment and effective, appropriate follow
    through are essential
  • Flowcharting the process is a vital piece of the
    teams work
  • The process of medication reconciliation upon
    admission is time-consuming. Obtaining staff
    buy-in to incorporate a new process into workflow
    design can be challenging
  • The FMEA process promotes positive cultural
    change within the organization

14
Resources
  • Failure Mode and Effects Analysis (FMEA)
  • Stoll, HW. Product Design Methods and Practices.
    New York Marcel Dekker, Inc., 1999.
  • From Potential Failure Mode and Effects Analysis
    (FMEA) 3rd Edition. Reference manual developed
    by the FMEA teams at Chrysler, Ford and General
    Motors working under the auspices of the
    Automotive Division of the American Society for
    Quality Control (ASQC) and the Automotive
    Industry Action Group (AIAG)
  • Strategies and Tips for Maximizing Failure Mode
    and Effect Analysis in your Organization. White
    Paper prepared by the American Society for
    Healthcare Risk Management, July 2002. Available
    at http//www.hospitalconnect.com/ashrm/resource
    s/files/FMEAwhitepaper.pdf. Accessed December 6,
    2002.
  • Burgmeier, J. Failure Mode and Effect Analysis
    An Application in Reducing Risk in Blood
    Transfusion. Journal on Quality Improvement.
    2002 28331-339.
  • DeRosier, J et al. Using Health Care Failure
    Mode and Effect AnalysisTM The VA National
    Center for Patient Safetys Prospective Risk
    Analysis System. Journal on Quality Improvement.
    2002 28248-267.

15
Questions and Discussion
Write a Comment
User Comments (0)
About PowerShow.com